Patents by Inventor Daniel T. Eitzman

Daniel T. Eitzman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100104502
    Abstract: The present invention relates to endothelial dysfunction. In particular, the present invention provides biomarkers of endothelial dysfunction (e.g., vascular disease), and compositions and methods of using the same. Compositions and methods of the present invention find use in, among other things, research, clinical, diagnostic, drug discovery, and therapeutic applications.
    Type: Application
    Filed: November 6, 2007
    Publication date: April 29, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Daniel T. Eitzman, Peter F. Bodary, Jonaton W. Homeister
  • Patent number: 5639726
    Abstract: The invention relates generally to peptides which decrease the half-life of active plasminogen activator inhibitor-1. This invention further relates to methods and compositions for using peptides which decrease the half-life of active plasminogen activator inhibitor-1. Further, the invention includes methods and compositions useful in clot lysis.
    Type: Grant
    Filed: September 30, 1994
    Date of Patent: June 17, 1997
    Assignees: The Regents of the University of Michigan, Henry Ford Health System
    Inventors: Daniel A. Lawrence, David Ginsburg, Joseph D. Shore, William P. Fay, Steven T. Olson, Ann Marie Francis-Chmura, Daniel T. Eitzman, Dell Paielli